METROPOLITAN HEALTH NETWORKS INC
10QSB, 1997-11-19
OFFICES & CLINICS OF DOCTORS OF MEDICINE
Previous: CALIFORNIA COMMUNITY BANCSHARES CORP, 8-K, 1997-11-19
Next: DIGITAL VIDEO SYSTEMS INC, 10QSB, 1997-11-19




<PAGE> 1


                                  UNITED STATES

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                   FORM 10-QSB

(Mark One)
      [X]   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 1997

                                    OR

      [ ]   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to________

                         Commission file number 0-28456

                       METROPOLITAN HEALTH NETWORKS, INC.
             (Exact name of registrant as specified in its charter)


           Florida                                         65-0635748
(State or other jurisdiction of                        (I.R.S. Employer
 incorporation or organization)                         Identification No.)


5100 Town Center Circle, Boca Raton, Florida                 33486
  (Address of principal executive office)                 (Zip Code)


                                 (561) 416-9484
              (Registrant's telephone number, including area code)


     Indicate  by check mark  whether the  registrant  (1) has filed all reports
required to be filed by section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

Yes  X    No 
    ---      ---
  
     Indicate the number of shares  outstanding of each of the issuer's  classes
of common stock, as of the latest practicable date.

                  Class                 Outstanding as of November, 14, 1997
    ------------------------------      ------------------------------------
    Common Stock, par value $0.001                    5,465,867



<PAGE> 2

                       METROPOLITAN HEALTH NETWORKS, INC.

                                      INDEX


                                                                 Page No.
                                                                 --------
                                                           
PART I. FINANCIAL INFORMATION                              
                                                           
  Item 1. Financial Statements                             
                                                           
          Condensed Consolidated Balance Sheet-            
            September 30, 1997                                       3
                                                           
          Condensed Consolidated Statements of             
            Operations for the Three Months Ended          
            September 30, 1997 and 1996                              4
                                                           
          Condensed Consolidated Statements of             
            Cash Flows for the Three Months Ended          
            September, 1997                                        5-6
                                                           
          Notes to Condensed Consolidated                  
            Financial Statements                                     7
                                                           
  Item 2. Management's Discussion and Analysis             
            of Financial Condition and Results             
            of Operations                                            8
                                                           
                                                           
                                                           
SIGNATURES                                                           9
                                                           

















<PAGE> 3


METROPOLITAN HEALTH NETWORKS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)

<TABLE>
<CAPTION>
                                                                  September 30,
                                                                       1997
                                                                   ------------
<S>                                                                <C>    
ASSETS
CURRENT ASSETS:
Cash                                                               $    467,683
Marketable securities                                                   237,144
Accounts receivable, net                                              5,080,401
Other current assets                                                    215,373
                                                                   ------------

Total current assets                                                  6,000,601

PROPERTY AND EQUIPMENT, net                                           4,302,814

INTANGILBLE ASSETS, net                                               3,226,478

DEFERRED ACQUISITION COSTS                                              128,922

OTHER ASSETS                                                            397,786
                                                                   ------------

TOTAL                                                              $ 14,056,601
                                                                   ============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses                              $  1,224,488
Line of credit facility                                                 585,076
Current maturities of capital lease obligations                         632,152
Current maturities of long-term debt                                    630,942
                                                                   ------------

Total current liabilities                                             3,072,658

LONG TERM DEBT                                                          242,325

CAPITAL LEASE OBLIGATIONS                                             2,647,794

Total liabilities                                                     5,962,777
                                                                   ------------

COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY:
Common stock, par value $.001 per share:
  40,000,000 shares authorized;
  5,444,479 shares issued and outstanding                                 5,444
Preferred Stock, par value $ .001 per share,
  Stated value $100 per share
  10,000,000 shares authorized
  5,000 issued and outstanding                                          500,000
Additional paid-in capital                                            9,845,462
Retained earnings (deficit)                                          (2,257,082)
                                                                   ------------

Total stockholders' equity                                            8,093,824
                                                                   ------------

TOTAL                                                              $ 14,056,601
                                                                   ============
</TABLE>

See notes to condensed consolidated financial statements--unaudited 


<PAGE> 4


METROPOLITAN HEALTH NETWORKS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)

<TABLE>
<CAPTION>
                                                     For the Three Months Ended
                                                           September 30,
                                                    --------------------------- 
                                                        1997           1996
                                                    ------------   ------------
                                                                      (Note 2)
<S>                                                 <C>            <C>                                                     
REVENUES:                                   
Net patient revenues                                $  2,932,261   $  2,978,293
                                                    ------------   ------------
                                            
                                            
EXPENSES:                                   
Salaries and benefits                                  1,527,049      1,484,199
Depreciation and amortization                            316,723        257,934
General and administrative                             1,496,960      1,435,810
                                                    -------------  ------------
                                            
Total Expenses                                         3,340,732      3,177,943
                                                    -------------  ------------
                                            
INCOME (LOSS) FROM OPERATIONS                           (408,471)      (199,650)
                                                    -------------  -------------
                                            
OTHER INCOME (EXPENSE):                     
Gain on sale of asset                                       ----         91,384
Interest expense                                        (115,907)       (88,952)
Other income                                              15,290         19,517
                                                    -------------  ------------
                                            
Total Other Income (Expense)                            (100,617)        21,949
                                                    -------------  ------------
                                            
                                            
NET INCOME (LOSS)                                   $   (509,088)  $   (177,701)
                                                    ============   ============
                                            
                                            
NET LOSS PER COMMON SHARE                                 $ 0.09         $ 0.03
                                                          ======         ======
                                            
</TABLE>
                                       




See notes to condensed consolidated financial statements--unaudited.



<PAGE> 5

METROPOLITAN HEALTH NETWORKS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

<TABLE>
<CAPTION>
                                                                For the Three
                                                                 Months Ended
                                                             September 30, 1997
                                                             ------------------
<S>                                                               <C>         
Increase (Decrease) in Cash and equivalents from:

OPERATING ACTIVITIES:
Net Loss                                                          $  (509,088)
Adjustments to reconcile net cash provided
 by operating activities:
    Depreciation and amortization                                     316,723
    Provision for bad debts                                           266,448
    Stock issued in lieu of cash                                       37,500
Changes in assets and liabilities:
    Accounts receivable, net                                         (471,940)
    Trading securities                                                112,658
    Other current assets                                              (67,147)
    Other assets                                                     (147,550)
    Accounts payable and accrued expenses                             201,501
                                                                  -----------

Net cash used in operating activities                                (260,895)
                                                                  -----------

INVESTING ACTIVITIES:
Capital expenditures                                                 (233,972)
Deferred acquisition costs                                              7,584
Cash consideration paid for Company acquired                         (300,000)
Cash balance of Company acquired                                       44,188

Net cash used in investing activities                                (482,200)
                                                                  -----------

FINANCING ACTIVITIES:
Repayments on lines-of-credit                                         (43,425)
Repayment of notes to redeemed partners                              (442,500)
Repayments of capital lease obligations                              (413,684)
Issuance of preferred stock                                           442,500
                                                                  -----------

Net cash provided by financing activities                            (457,109)
                                                                  -----------


NET DECREASE IN CASH                                                1,200,204

CASH AND EQUIVALENTS AT BEGINNING OF PERIOD                         1,667,887
                                                                  -----------
CASH AND EQUIVALENTS AT END OF PERIOD                             $   467,683
                                                                  ===========

Supplemental Disclosures:
  Interest paid                                                   $   130,410
                                                                  ===========
  Income taxes paid                                               $      --
                                                                  ===========

</TABLE>



See notes to condensed consolidated financial statements--unaudited.


<PAGE> 6

METROPOLITAN HEALTH NETWORKS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)
(Unaudited)


NON-CASH INVESTING AND FINANCING ACTIVITIES:


Effective  July 1, 1997  Metropolitan  Health  Networks,  Inc.  acquired 100% of
Martin  Harrison MD, PA (D/B/A  General  Medical  Associates).  A summary of the
acquisition is as follows:


Consideration:
  Fair value of stock issued           $1,189,000
  Issuance of notes payable               400,000
  Assumption of liabilities                32,000
                                       ----------
    Total consideration                $1,621,000
                                       ==========






































<PAGE> 7

METROPOLITAN   HEALTH  NETWORKS,   INC.  AND  SUBSIDIARIES  NOTES  TO  CONDENSED
CONSOLIDATED FINANCIAL STATEMENTS--Unaudited


1.    The  accompanying  condensed  consolidated  balance sheet of  Metropolitan
Health  Networks,  Inc.  ("Metropolitan"  or the  "Company") as of September 30,
1997, the related condensed consolidated  statements of operations for the three
months  ended  September  30,  1997  and  1996  and the  condensed  consolidated
statements  of cash flows for the three months ended  September 30, 1997 reflect
all normal  recurring  adjustments  which  are,  in the  opinion of  management,
necessary for a fair presentation of such statements.  The results of operations
for the three months ended September 30, 1997 are not necessarily  indicative of
the results which may be expected for the entire year. These  statements  should
be read in conjunction with the audited  consolidated  financial  statements and
notes thereto for the year ended June 30, 1997  included in the  Company's  form
10-KSB filed with the Securities and Exchange Commission.


2.    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION-- The condensed  consolidated  financial  statements
include  Metropolitan Health Networks,  Inc. and its subsidiaries.  All material
intercompany accounts and transactions have been eliminated.


FINANCIAL  RESULTS  FOR  THE  THREE  MONTHS  ENDED  SEPTMEBER  30,  1996  -  For
comparative purposes, the results of operations for this period were prepared on
a pro forma basis as if the  subsidiaries  owned by the Company  included in the
results of operations for the period ended  September 30, 1997 had been acquired
as of July 1,1996.


SALE OF  PREFERRED  STOCK --- In July,  the  Company  sold  5,000  shares of 10%
Convertible  Preferred Stock in a private placement resulting in net proceeds to
the Company of $ 442,500.  The stock is  convertible  at 85% of the ten (10) day
moving average or $ 6.00 per share,  whichever is less and is callable after two
(2) years.  The agreement has demand  registration  rights on the anniversary of
the closing date of the agreement, and has piggy back rights on any registration
the  Company  completes,  and if the  Company  does not meet a  minimum  of $ 30
million  in run  rate  revenue  within  seven  (7)  months  from the date of the
agreement, the investor shall have demand registration rights.














<PAGE> 8

MANAGEMENT'S  DISCUSSION  AND  ANALYSIS OF  FINANCIAL  CONDITION  AND RESULTS OF
OPERATIONS

The following  discussion and analysis  provides  information  which  management
believes  is  relevant  to an  assessment  and  understanding  of the  Company's
consolidated  financial  condition  and results of  operations.  The  discussion
should  be  read  in  conjunction  with  the  condensed  consolidated  financial
statements and notes thereto.

Results of Operations

Three months ended  September 30, 1997 Compared to three months ended  September
30, 1996


Net patient  revenues  for the three months ended  September  30, 1997  declined
approximately  1.5% to $2.92  million,  as  compared  to $2.98  million  for the
corresponding quarter of 1996. This decline was due to a reduction in diagnostic
procedures  performed by one of its  subsidiaries.  This was partially offset by
the $140,000  generated by its billing group,  which started  non-related  party
billing and collection in June of 1997.

Total operating expenses for the three months ended September 30, 1997 increased
5.1% to $3.34  million,  as  compared  to $3.12  million  for the  corresponding
quarter of 1996.  This  increase was primarily  attributable  to the increase in
depreciation  from new equipment  purchased in the first half of fiscal 1997 and
the increase in personnel and related  costs due to the Company's  completion of
its initial public offering and expansion of its corporate services.

Total other  income  (expense)  for the three months  ended  September  30, 1997
decreased  to a net other  expense of $101,000 as compared to a net other income
of $22,000 for the corresponding quarter of 1996. This decrease is due to a gain
recognized on sale of certain assets during the first quarter of fiscal 1997.




Liquidity and Capital Resources

While the Company has working capital of  approximately  $3 million at September
30, 1997,  the Company's cash and cash  equivalents  decreased by more than $1.2
million  during  the last  quarter.  It is  anticipated  that the  Company  will
experience additional reductions in cash from operations for the next one to two
quarters. The Company  utilized  additional  reserves to open a new primary care
facility,  upgrade an existing  facility and complete the acquisition of General
Medical  Associates.  However  the  demands  on cash will be  lessened  due to a
reduction  in  losses  and  an  acceleration  in  collections  on  its  accounts
receivable.


A primary  source of the Company's  liquidity  will be derived from its accounts
receivable,  therefore it has selected,  designed and implemented an information
system which will link the network,  maximize billing,  and reduce the number of
days of sales in  accounts  receivable.  Additionally,  the  Company is in final
negotiations  for a line of credit,  which, if  consummated,  will be secured by
accounts  receivable.  The  Company  is also  in  negotiations  for the  sale of
additional preferred stock similar to the sale reflected in the first quarter of
fiscal 1998.


<PAGE> 9

SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.



                                      METROPOLITAN HEALTH NETWORKS, INC.

                                           Registrant





Date:  November 19, 1997                   /s/ Noel J. Guillama
                                           -------------------------------------
                                           Noel J. Guillama
                                           Chairman, President and
                                           Chief Executive Officer







Date:  November 19, 1997                   /s/ Donald B. Cohen
                                           -------------------------------------
                                           Donald B. Cohen
                                           Executive Vice President, Chief
                                           Finance Officer, Treasurer,
                                           Director





















<TABLE> <S> <C>


<ARTICLE> 5
<LEGEND>
THIS  SCHEDULE  CONTAINS  SUMMARY  FINANCIAL   INFORMATION  EXTRACTED  FROM  THE
FINANCIAL STATEMENTS OF METROPOLITAN HEALTH NETWORKS,  INC. FOR THE THREE MONTHS
ENDED  SEPTEMBER 30, 1997, AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1

        
<S>                             <C>

<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                         467,683
<SECURITIES>                                   237,144
<RECEIVABLES>                               12,024,196  
<ALLOWANCES>                                 6,943,795     
<INVENTORY>                                          0
<CURRENT-ASSETS>                             6,000,601
<PP&E>                                       5,134,439  
<DEPRECIATION>                                 834,625
<TOTAL-ASSETS>                              14,056,601 
<CURRENT-LIABILITIES>                        3,072,658
<BONDS>                                              0
                                0
                                    500,000 
<COMMON>                                         5,444 
<OTHER-SE>                                   7,588,380
<TOTAL-LIABILITY-AND-EQUITY>                14,056,601 
<SALES>                                      2,932,261
<TOTAL-REVENUES>                             2,932,261
<CGS>                                                0
<TOTAL-COSTS>                                3,340,732
<OTHER-EXPENSES>                               (15,290)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             115,907
<INCOME-PRETAX>                               (509,088) 
<INCOME-TAX>                                         0 
<INCOME-CONTINUING>                           (509,088)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0      
<CHANGES>                                            0 
<NET-INCOME>                                  (509,088) 
<EPS-PRIMARY>                                    (0.09)  
<EPS-DILUTED>                                    (0.09)     

        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission